Guest Post by Ryan - Lamprecht AG, a condom manufacturer in Switzerland, has recently announced that they are bringing in condoms for 12 year old boys in a bid to try and stop the amount of teen pregnancies that are occurring.
Read more »Is It Wrong To Create Condoms For Children Age 12 And Up?
Men’s Skin Care Products Becoming More Acceptable
Skin products for men are nothing new. In fact, it could be argued that men have been using natural products on their skin for thousands of years. The Greeks reportedly used mud packs and Roman’s covered sensitive areas with natural yogurt to soften the skin and reduce blemishes.
Read more »
Category: Health News Tags:
DVT More of a Risk for Bowl Disease Sufferers
Guest post by Duncan
March 2, 2010 - Deep vein thrombosis (DVT) is something of a hot topic at the moment, with growing numbers of people suffering from the condition and increased awareness from airlines after elevated levels of mid-flight deaths.
Read more »Fight HIV with HIV: 'safe' virus proposed as vaccine
Feburary 19, 2010 - By Andy Coghlan (The NewScientist). A company is planning to inject people with an HIV vaccine made of the deadly virus itself, albeit a deactivated version.
Read more »
Category: Health News Tags:
Study links sugary soft drinks to pancreas cancer
WASHINGTON, Feb 8, 2010 (Reuters) - People who drink two or more sweetened soft drinks a week have a much higher risk of pancreatic cancer, an unusual but deadly cancer, researchers reported on Monday.
People who drank mostly fruit juice instead of sodas did not have the same risk, the study of 60,000 people in Singapore found.
Read more »Haiti doctors fear malaria and typhoid as rainy season arrives
With a million Haitians homeless and disease spreading, the earthquake-shattered island is threatened by other natural forces.
Aid agencies are warning of an imminent health crisis in Haiti, as the onset of the rainy season brings fears of outbreaks of waterborne diseases in Port-au-Prince's squalid refugee camps.
Read more »"Silent pandemic" will force drug price rethink
January 20,2010 - LONDON (Reuters) - A "silent pandemic" of chronic disease is creeping up on poor countries and will force pharmaceutical firms to take a more tiered approach to pricing some of their most lucrative medicines.
Drugs for diseases which were previously dominant only in the rich, well-fed world, such as diabetes, heart disease and cancer, are increasingly in demand in poorer nations in Asia and Africa, whose populations are now living longer.
But the price of many of these medicines and their unsuitability for emerging markets are high barriers to access.
Read more »China Investigates Deaths After Swine Flu Shot
November 16, 2009 - Chinese health officials reported on Friday the first deaths in people who received the H1N1 vaccine. The Ministry of Health announced that the two people, including one teacher from Hunan province, died hours after receiving their inoculations. Since September, when the Ministry began its H1N1 immunization program, 12 million Chinese have received the pandemic flu shot.
A preliminary autopsy revealed that the teacher died of an apparent heart attack while playing basketball, and a Ministry spokesperson told the China Daily newspaper that the death was "a coincidental medical incident" and not related to the vaccine. No details on the second victim have been released so far.
Read more »Three US Scientists Win 2009 Nobel Prize in Physiology and Medicine
Oct. 5, 2009 - STOCKHOLM: Elizabeth Blackburn, Carol W. Greider and Jack Szoztak deciphered the enigma of how chromosomes are protected by telomeres and the enzyme telomerase.
The Karolinska Institute has awarded this year's Nobel Prize in Physiology or Medicine to three US scientists (two women and one man) who solved one of the greatest mysteries of biology: how chromosomes can be copied in a complete way during cell divisions and how they are protected against degradation.
Read more »Experimental Vaccine Reduces Risks Of HIV/AIDS Contagion
Sept. 24, 2009 - Thai health authorities have presented yesterday in Bangkok the results of an HIV/AIDS vaccine studey conducted on more than 16,000 people.
The study conducted in Thailand was sponsored by the US Army Medical Research and the National Institute of Health.
The experimental vaccine (known as RV144) is a combination of two genetically engineered vaccines developed by Sanofi-Aventis SA and VaxGen Inc., whih had failed in previous trials.
The protection offered by this new vaccine is very low, as it only reduces the risk of contagion by 31.2 percent, but the results give some indication that researchers are heading in the right direction.
Read more »
